CD4+ T lymphocytes mediated protection against invasive pneumococcal infection induced by mucosal immunization with ClpP and CbpA

Vaccine

Volumn 27, Issue 21, 2009, Pages 2838-2844

  Cao, Ju ^a   Gong, Yi ^a   Li, Dairong ^a   Yin, Nanlin ^a   Chen, Tingmei ^a   Xu, Wenchun ^a   Zhang, Xuemei ^a   Yin, Yibing ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

CD4+ T lymphocytes; Streptococcus pneumoniae; Vaccine

Indexed keywords

BACTERIAL PROTEIN; CASEINOLYTIC PROTEASE PLUS CHOLINE BINDING PROTEIN A PNEUMOCOCCUS VACCINE; CD4 ANTIGEN; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; PNEUMOCOCCUS VACCINE; STREPTOCOCCUS ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBODY PRODUCTION; ARTICLE; BACTERIUM ADHERENCE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG MIXTURE; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNIZATION; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIBODIES; APOPTOSIS; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; MICE; PNEUMOCOCCAL INFECTIONS; SERINE ENDOPEPTIDASES;

EID: 64449086480     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.093     Document Type: Article

References (42)

1. Bogaert D., De Groot R., and Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4 3 (2004) 144-154
2. Briles D.E., Hollingshead S.K., Paton J.C., Ades E.W., Novak L., van Ginkel F.W., et al. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis 188 3 (2003) 339-348
3. Tai S.S. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit Rev Microbiol 32 3 (2006) 139-153
4. Dave S., Carmicle S., Hammerschmidt S., Pangburn M.K., and McDaniel L.S. Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol 173 1 (2004) 471-477
5. Zhang J.R., Mostov K.E., Lamm M.E., Nanno M., Shimida S., Ohwaki M., et al. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102 6 (2000) 827-837
6. Ogunniyi A.D., Woodrow M.C., Poolman J.T., and Paton J.C. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect Immun 69 10 (2001) 5997-6003
7. Robertson G.T., Ng W.L., Foley J., Gilmour R., and Winkler M.E. Global transcriptional analysis of clpP mutations of type 2 Streptococcus pneumoniae and their effects on physiology and virulence. J Bacteriol 184 13 (2002) 3508-3520
8. Kwon H.Y., Ogunniyi A.D., Choi M.H., Pyo S.N., Rhee D.K., and Paton J.C. The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge. Infect Immun 72 10 (2004) 5646-5653
9. Spratt B.G., and Greenwood B.M. Prevention of pneumococcal disease by vaccination: does serotype replacement matter?. Lancet 356 9237 (2000) 1210-1211
10. Wu H.Y., Nahm M.H., Guo Y., Russell M.W., and Briles D.E. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis 175 4 (1997) 839-846
11. Kane M. Unsafe injections. Bull World Health Organ 76 1 (1998) 99-100
12. Overturf G.D. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 106 2 Pt 1 (2000) 367-376
13. Kroon F.P., van Dissel J.T., Ravensbergen E., Nibbering P.H., and van Furth R. Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations. Vaccine 18 5-6 (1999) 524-530
14. Malley R., Lipsitch M., Stack A., Saladino R., Fleisher G., Pelton S., et al. Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun 69 8 (2001) 4870-4873
15. + T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci USA 102 13 (2005) 4848-4853
16. + T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun 75 11 (2007) 5460-5464
17. Cao J., Chen T., Li D., Wong C.K., Chen D., Xu W., et al. Mucosal immunization with purified ClpP could elicit protective efficacy against pneumococcal pneumonia and sepsis in mice. Microbes Infect 10 14-15 (2008) 1536-1542
18. Ogunniyi A.D., Grabowicz M., Briles D.E., Cook J., and Paton J.C. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect Immun 75 1 (2007) 350-357
19. Cao J., Chen D., Xu W., Chen T., Xu S., Luo J., et al. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Vaccine 25 27 (2007) 4996-5005
20. Mizrachi Nebenzahl Y., Bernstein A., Portnoi M., Shagan M., Rom S., Porgador A., et al. Streptococcus pneumoniae surface-exposed glutamyl tRNA synthetase, a putative adhesin, is able to induce a partially protective immune response in mice. J Infect Dis 196 6 (2007) 945-953
21. Giefing C., Meinke A.L., Hanner M., Henics T., Bui M.D., Gelbmann D., et al. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med 205 1 (2008) 117-131
22. + T cells against influenza virus induced by vaccination with nucleoprotein DNA. J Virol 72 7 (1998) 5648-5653
23. Brooks-Walter A., Briles D.E., and Hollingshead SK. The PspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun 67 12 (1999) 6533-6542
24. Bernatoniene J., Zhang Q., Dogan S., Mitchell T.J., Paton J.C., and Finn A. Induction of CC and CXC Chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4, NF-kappaB, and mitogen-activated protein kinases. J Infect Dis 198 12 (2008) 1823-1833
25. Orihuela C.J., Gao G., Francis K.P., Yu J., and Tuomanen E.I. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190 9 (2004) 1661-1669
26. Ogunniyi A.D., Giammarinaro P., and Paton J.C. The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. Microbiology 148 Pt 7 (2002) 2045-2053
27. Orihuela C.J., Radin J.N., Sublett J.E., Gao G., Kaushal D., and Tuomanen E.I. Microarray analysis of pneumococcal gene expression during invasive disease. Infect Immun 72 10 (2004) 5582-5596
28. Kerr A.R., Irvine J.J., Search J.J., Gingles N.A., Kadioglu A., Andrew P.W., et al. Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect Immun 70 3 (2002) 1547-1557
29. Rubins J.B., and Pomeroy C. Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun 65 7 (1997) 2975-2977
30. Malley R., Srivastava A., Lipsitch M., Thompson C.M., Watkins C., Tzianabos A., et al. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun 74 4 (2006) 2187-2195
31. Lu Y.J., Gross J., Bogaert D., Finn A., Bagrade L., Zhang Q., et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4 9 (2008) e1000159
32. Zhu J., and Paul W.E. CD4 T cells: fates, functions, and faults. Blood 112 5 (2008) 1557-1569
33. Kadioglu A., Coward W., Colston M.J., Hewitt C.R., and Andrew P.W. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect Immun 72 5 (2004) 2689-2697
34. Baril L., Dietemann J., Essevaz-Roulet M., Béniguel L., Coan P., Briles D.E., et al. Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults. Clin Exp Immunol 145 2 (2006) 277-286
35. Kadioglu A., Weiser J.N., Paton J.C., and Andrew P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6 4 (2008) 288-301
36. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25 30 (2007) 5467-5484
37. Cerundolo V., Silk J.D., Masri S.H., and Salio M. Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol 9 1 (2009) 28-38
38. Wright A.K., Briles D.E., Metzger D.W., and Gordon S.B. Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection. Vaccine 26 38 (2008) 4893-4903
39. Ferreira D.M., Darrieux M., Oliveira M.L., Leite L.C., and Miyaji E.N. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production. Clin Vaccine Immunol 15 3 (2008) 499-505
40. Schmidt-Weber C.B., Akdis M., and Akdis C.A. TH17 cells in the big picture of immunology. J Allergy Clin Immunol 120 2 (2007) 247-254
41. Briles D.E., Ades E., Paton J.C., Sampson J.S., Carlone G.M., Huebner R.C., et al. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun 68 2 (2000) 796-800
42. Ogunniyi A.D., Folland R.L., Briles D.E., Hollingshead S.K., and Paton J.C. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect Immun 68 5 (2000) 3028-3033